Regulation of Kappa opioid receptor-mediated signaling and peripheral analgesia

Kappa 阿片受体介导的信号传导和外周镇痛的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Pain affects more Americans than does diabetes, heart disease and cancer combined. Opioids are a key drug class for pain treatment; however, there are significant drawbacks (e.g. CNS adverse effects, social and legal issues) that limit their use for effective management of pain. Consequently, development of novel approaches for improved pain control is a critically important research objective. To eliminate adverse CNS-derived effects, attention has turned to targeting peripherally located opioid receptors expressed on the pain-sensing neurons themselves. Importantly, the regulatory mechanisms of opioid receptor systems in peripheral sensory neurons are unique, and results obtained from studies in other systems (CNS, heterologous expression systems, etc.) do not always translate to peripheral sensory neurons. Thus, to understand opioid receptor function in peripheral sensory neurons, experiments must be done with peripheral sensory neurons. The goal of this project is to study the regulation of kappa opioid receptor (KOR) signaling systems in peripheral sensory neurons, using primary cultures of adult rat sensory neurons and a behavioral model of nociception. Our specific aims are 1) To delineate the role of ERK in regulation of KOR function in peripheral sensory neurons; 2) To delineate the role of JNK in regulation of KOR function in peripheral sensory neurons; and 3) To delineate the role of acute desensitization in regulating KOR agonist efficacy in peripheral sensory neurons. Our overall goal is to increase the reliability and therapeutic efficacy of peripherally-restricted kappa opioid analgesic drugs. By understanding the cellular mechanisms that are involved in regulating the responsiveness of kappa opioid receptor systems on peripheral sensory neurons, improved approaches to treat pain can be developed that have improved therapeutic efficacy and are devoid of debilitating CNS-mediated adverse effects. The combination of rigorous mechanistic studies using primary sensory neurons in culture with the translational value of behavioral studies provides a powerful approach to understanding the regulation of kappa opioid receptor agonist efficacy in a physiologically relevant system and may lead to new approaches for improved pharmacotherapy for pain.
描述(由申请人提供):疼痛影响更多的美国人比糖尿病,心脏病和癌症的总和。阿片类药物是疼痛治疗的关键药物类别;然而,存在显著的缺点(例如CNS不良反应、社会和法律的问题),限制了其用于有效管理疼痛。因此,开发新的方法来改善疼痛控制是一个至关重要的研究目标。为了消除CNS衍生的不良作用,人们的注意力转向靶向外周定位的阿片受体表达的疼痛感觉神经元本身。重要的是,阿片受体系统在外周感觉神经元中的调节机制是独特的,并且从其他系统(CNS、异源表达系统等)中的研究获得的结果也是独特的。并不总是转化为外周感觉神经元。因此,为了了解外周感觉神经元中阿片受体的功能,必须对外周感觉神经元进行实验。 本研究的目的是利用成年大鼠感觉神经元的原代培养和伤害感受的行为模型,研究外周感觉神经元中κ阿片受体(KOR)信号系统的调节。我们的具体目标是:1)阐明ERK在外周感觉神经元中调节KOR功能的作用; 2)阐明JNK在外周感觉神经元中调节KOR功能的作用; 3)阐明急性脱敏在外周感觉神经元中调节KOR激动剂功效的作用。 我们的总体目标是提高外周限制性kappa阿片类镇痛药物的可靠性和治疗效果。通过了解参与调节κ阿片受体系统对外周感觉神经元的反应性的细胞机制,可以开发具有改善的治疗功效并且没有使CNS介导的不良反应的治疗疼痛的改进方法。使用初级感觉神经元培养的严格机制研究与行为研究的转化价值相结合,提供了一种强有力的方法来理解κ阿片受体激动剂在生理相关系统中的调节作用,并可能导致改善疼痛药物治疗的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM P CLARKE其他文献

WILLIAM P CLARKE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM P CLARKE', 18)}}的其他基金

Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
DOR-KOR 异聚体介导的外周镇痛变构分子的鉴定
  • 批准号:
    10608439
  • 财政年份:
    2023
  • 资助金额:
    $ 27.95万
  • 项目类别:
Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons
开发抑制外周痛觉神经元的新型化合物的表型筛选试验
  • 批准号:
    10650640
  • 财政年份:
    2023
  • 资助金额:
    $ 27.95万
  • 项目类别:
Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder
MCAM 的药理和行为影响:一种长效、μ阿片受体拮抗剂,用于治疗阿片类药物过量和阿片类药物滥用障碍
  • 批准号:
    10091419
  • 财政年份:
    2019
  • 资助金额:
    $ 27.95万
  • 项目类别:
Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder
MCAM 的药理和行为影响:一种长效、μ阿片受体拮抗剂,用于治疗阿片类药物过量和阿片类药物滥用障碍
  • 批准号:
    9923616
  • 财政年份:
    2019
  • 资助金额:
    $ 27.95万
  • 项目类别:
Aging, peripheral pain and analgesia
衰老、末梢疼痛和镇痛
  • 批准号:
    8824054
  • 财政年份:
    2015
  • 资助金额:
    $ 27.95万
  • 项目类别:
KOR agonist functional selectivity in peripheral sensory neurons
KOR 激动剂在外周感觉神经元中的功能选择性
  • 批准号:
    9301785
  • 财政年份:
    2015
  • 资助金额:
    $ 27.95万
  • 项目类别:
Regulation of Kappa opioid receptor-mediated signaling and peripheral analgesia
Kappa 阿片受体介导的信号传导和外周镇痛的调节
  • 批准号:
    8794814
  • 财政年份:
    2014
  • 资助金额:
    $ 27.95万
  • 项目类别:
Regulation of Kappa opioid receptor-mediated signaling and peripheral analgesia
Kappa 阿片受体介导的信号传导和外周镇痛的调节
  • 批准号:
    8632174
  • 财政年份:
    2014
  • 资助金额:
    $ 27.95万
  • 项目类别:
Regulation of DOR-KOR heteromer formation in pain-sensing neurons
痛觉神经元中 DOR-KOR 异聚体形成的调节
  • 批准号:
    8824055
  • 财政年份:
    2014
  • 资助金额:
    $ 27.95万
  • 项目类别:
Regulation of opioid receptor function in trigeminal ganglion
三叉神经节阿片受体功能的调节
  • 批准号:
    8094524
  • 财政年份:
    2009
  • 资助金额:
    $ 27.95万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 27.95万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了